GridAI Technologies (GRDX) Long-Term Deferred Tax (2016 - 2021)
GridAI Technologies' (GRDX) quarterly Long-Term Deferred Tax came in at $31.6 million in Q4 2021, up 21.07% YoY from $26.1 million in Q4 2020, and up 15.75% on a QoQ basis from $27.3 million in Q2 2021.
GridAI Technologies (GRDX) Long-Term Deferred Tax (2016 - 2021) Analysis & Trends
GridAI Technologies (GRDX) has 6 years of Long-Term Deferred Tax data on file, last reported at $31.6 million in Q4 2021.
- Quarterly Long-Term Deferred Tax rose 21.07% year-over-year to $31.6 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $31.6 million (up 21.07% YoY) and the FY2021 annual result came in at $31.6 million, up 21.07% from the prior year.
- Long-Term Deferred Tax advanced to $31.6 million in Q4 2021, from $27.3 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $31.6 million in Q4 2021 to a low of $9.0 million in Q1 2017.
- A 5-year average of $17.0 million and a median of $15.3 million in 2019 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2018 — Long-Term Deferred Tax gained 6.59% — and 2021, when it jumped 60.63%.
- Tracing GRDX's Long-Term Deferred Tax over 5 years: stood at $11.3 million in 2017, then rose by 6.59% to $12.0 million in 2018, then jumped by 34.34% to $16.2 million in 2019, then surged by 61.55% to $26.1 million in 2020, then advanced by 21.07% to $31.6 million in 2021.
- The last three Long-Term Deferred Tax figures came in at $31.6 million (Q4 2021), $27.3 million (Q2 2021), and $25.0 million (Q1 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 31.60 Mn |
| Jun 30, 2021 | 27.30 Mn |
| Mar 31, 2021 | 25.00 Mn |
| Dec 31, 2020 | 26.10 Mn |
| Sep 30, 2020 | 20.06 Mn |
| Jun 30, 2020 | 17.00 Mn |
| Mar 31, 2020 | 16.02 Mn |
| Sep 30, 2019 | 16.16 Mn |
| Jun 30, 2019 | 14.50 Mn |
| Mar 31, 2019 | 13.65 Mn |
| Sep 30, 2018 | 12.03 Mn |
| Jun 30, 2018 | 11.32 Mn |
| Mar 31, 2018 | 10.84 Mn |
| Sep 30, 2017 | 11.28 Mn |
| Jun 30, 2017 | 10.21 Mn |
| Mar 31, 2017 | 9.04 Mn |
| Dec 31, 2016 | 6.96 Mn |